Although still in early phases, preclinical studies have demonstrated that gene editing approaches targeting RPGR, including CRISPR-mediated frame restoration in ORF15, can successfully rescue photoreceptor structure and function in RP models [29,59,60]. This evidence concerns the gene RPGR and retinitis pigmentosa 1.